Description
Movinaza-10 (Serratiopeptidase) Coated Enteric Tablets 10 mg. №30
Ingredients
- Active ingredient: Serratiopeptidase 10 mg
- Other ingredients: enteric coating, microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide
Dosage
Recommended dosage: Take 1 tablet daily on an empty stomach with water, or as directed by a healthcare professional
Indications
Movinaza-10 is indicated for its anti-inflammatory properties and is commonly used to support the body’s natural healing process
Contraindications
Do not use Movinaza-10 if you are allergic to serratiopeptidase or any other ingredients in the product. Consult a healthcare provider before use if pregnant, nursing, or taking other medications
Directions
Directions for use: Swallow the tablet whole, do not crush or chew. Follow the dosage instructions provided unless otherwise directed by a healthcare professional
Scientific Evidence
Serratiopeptidase, the active ingredient in Movinaza-10, has been studied for its anti-inflammatory and analgesic properties. Research suggests that serratiopeptidase may help reduce swelling, pain, and improve tissue repair processes. A study published in the Asian Journal of Pharmaceutical Sciences demonstrated the efficacy of serratiopeptidase in reducing inflammation in patients with osteoarthritis
Additional Information
Movinaza-10 coated enteric tablets are designed to bypass the acidic environment of the stomach and dissolve in the alkaline environment of the intestines, ensuring optimal absorption of the active ingredient. It is important to store the product in a cool, dry place away from direct sunlight
Pharmacological Effects: Serratiopeptidase works by breaking down proteins that are involved in inflammation and pain, helping to reduce swelling and improve tissue healing. It is commonly used in conditions where inflammation plays a key role, such as arthritis and post-operative recovery
Clinical Trials: Clinical trials have shown promising results in the use of serratiopeptidase for various inflammatory conditions. A randomized controlled trial published in the Journal of Alternative and Complementary Medicine found that serratiopeptidase was effective in reducing pain and swelling in patients with carpal tunnel syndrome
